An open letter to the FDA regarding changes in reporting procedures for drugs and biologics proposed in the wake of the FIAU tragedy

Controlled Clinical Trials

Volumn 17, Issue 4, 1996, Pages 273-284

  Meinert, C L ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG SAFETY; ECONOMICS; ETHICS; FOOD AND DRUG ADMINISTRATION; INFORMATION PROCESSING; LAW; SHORT SURVEY;

EID: 0029843341     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-2456(95)00257-X     Document Type: Article

References (0)